Security
BIOCEPT INC Common Stock · BIOCQ
BIOCQOTCCommon stockCurrentCIK 1044378Updated Nov 16, 2026
BIOCQ price & chart
Loading TradingView…
OTC:BIOCQ on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 30,873,000Source | 60,417,000Source | 47,451,586Source | 17,732,644Source |
| Property, Plant and Equipment, NetUSD | 2,572,000Source | 2,401,000Source | 2,317,616Source | 1,504,330Source |
| Current assets: | ||||
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,151,000Source | 13,786,000Source | 14,144,911Source | 3,527,078Source |
| Inventory, NetUSD | 757,000Source | 2,651,000Source | 1,929,624Source | 767,986Source |
| Assets, CurrentUSD | 16,343,000Source | 45,692,000Source | 32,594,004Source | 13,892,597Source |
| Prepaid Expense and Other Assets, CurrentUSD | 538,000Source | 391,000Source | 2,151,527Source | 296,127Source |
| Operating Lease, Right-of-Use AssetUSD | 8,486,000Source | 9,026,000Source | 9,776,349Source | 729,330Source |
| Other Assets, NoncurrentUSD | 386,000Source | 456,000Source | 425,908Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 22,013,000Source | 22,937,000Source | 23,759,164Source | 6,532,001Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 2,000Source | 2,000Source | 1,340Source | 5,474Source |
| Retained Earnings (Accumulated Deficit)USD | -298,438,000Source | -266,351,000Source | -263,526,867Source | -245,717,189Source |
| Stockholders' Equity Attributable to ParentUSD | 8,860,000Source | 37,480,000Source | 23,692,422Source | 11,200,643Source |
| Additional Paid in Capital, Common StockUSD | 307,296,000Source | 303,829,000Source | 287,217,949Source | 256,912,358Source |
| Liabilities and EquityUSD | 30,873,000Source | 60,417,000Source | 47,451,586Source | 17,732,644Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 5,506,000Source | 11,773,000Source | 12,494,253Source | 5,558,812Source |
| Operating Lease, Liability, CurrentUSD | 518,000Source | 426,000Source | — | 842,452Source |
| Accounts Payable, CurrentUSD | 1,523,000Source | 7,246,000Source | 8,364,858Source | 2,011,827Source |
| Operating Lease, Liability, NoncurrentUSD | 9,175,000Source | 9,736,000Source | 9,805,361Source | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 2,249,000Source | 3,018,000Source | 3,165,669Source | 1,980,204Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -32,087,000Source | -2,824,000Source | -17,806,904Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 3,227,000Source | 2,462,000Source | 940,984Source | 869,579Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -11,636,000Source | -358,000Source | 10,617,833Source | 1,952,753Source |
| Increase (Decrease) in InventoriesUSD | -1,894,000Source | 828,000Source | 1,406,464Source | 194,928Source |
| Increase (Decrease) in Accounts PayableUSD | -5,860,000Source | -411,000Source | 4,463,722Source | 14,838Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -13,289,000Source | 3,690,000Source | -19,787,100Source | -23,049,261Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -807,000Source | -1,572,000Source | -866,814Source | -735,300Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 807,000Source | 1,572,000Source | 866,814Source | 735,300Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -1,871,000Source | 12,378,000Source | 25,720,450Source | 29,662,594Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -15,967,000Source | 14,496,000Source | 5,066,536Source | 5,878,033Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 316,000Source | 290,000Source | 236,540Source | 249,984Source |
| Additional Financial Items | ||||
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -9,000Source | -4,000Source | 1,680Source | — |
| General and Administrative ExpenseUSD | 16,113,000Source | 12,614,000Source | 9,973,082Source | 6,970,120Source |
| Income Tax Expense (Benefit)USD | -125,000Source | 125,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -32,087,000Source | -2,824,000Source | -17,806,904Source | -25,138,039Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -32,087,000Source | -2,824,000Source | -17,809,678Source | -25,259,611Source |
| Nonoperating Income (Expense)USD | -229,000Source | -290,000Source | -2,338,649Source | -2,081,100Source |
| Other Nonoperating Income (Expense)USD | 87,000Source | — | — | — |
| Proceeds from Issuance of Common StockUSD | 240,000Source | — | — | — |
| Proceeds from Stock Options ExercisedUSD | — | 2,000Source | — | — |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | 25,858,000Source | 61,249,000Source | 27,461,398Source | 5,528,566Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Operating Income (Loss)USD | -31,983,000Source | -2,409,000Source | -15,468,255Source | -23,056,939Source |
| Other Nonoperating Income (Expense)USD | 87,000Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -32,212,000Source | -2,699,000Source | -17,806,904Source | -25,138,039Source |
| Income Tax Expense (Benefit)USD | -125,000Source | 125,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -32,087,000Source | -2,824,000Source | -17,806,904Source | -25,138,039Source |
| Earnings Per Share, BasicUSD per share | -1.89Source | -0.19Source | -1.5Source | -1.22Source |
| Earnings Per Share, DilutedUSD per share | -1.89Source | -0.19Source | -1.5Source | -1.22Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 16,953,812Source | 14,775,805Source | 11,845,255Source | 20,660,894Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 16,953,812Source | 14,775,805Source | 11,845,255Source | 20,660,894Source |
| Additional Financial Items | ||||
| Costs and ExpensesUSD | 57,841,000Source | 63,658,000Source | 42,929,653Source | 28,585,505Source |
| Current Income Tax Expense (Benefit)USD | -125,000Source | 125,000Source | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | 1,655,000Source | 1,530,000Source | 1,085,234Source | 931,655Source |
| General and Administrative ExpenseUSD | 16,113,000Source | 12,614,000Source | 9,973,082Source | 6,970,120Source |
| Interest ExpenseUSD | 316,000Source | 290,000Source | 236,540Source | 249,984Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -32,087,000Source | -2,824,000Source | -17,809,678Source | -25,259,611Source |
| Nonoperating Income (Expense)USD | -229,000Source | -290,000Source | -2,338,649Source | -2,081,100Source |
| Research and Development ExpenseUSD | 6,161,000Source | 4,960,000Source | 5,220,278Source | 4,697,022Source |
| Selling and Marketing ExpenseUSD | 7,127,000Source | 8,320,000Source | 6,399,502Source | 5,940,843Source |